Anti-b diminishes hyperlipidaemia and hepatic steatosis in hamsters and mice by suppressing the mTOR/PPARγ and mTOR/SREBP1 signalling pathways.
Bian Y, Wu H, Jiang W, Kong X, Xiong Y, Zeng L, Zhang F, Song J, Wang C, Yang Y, Zhang X, Zhang Y, Pang P, Duo T, Wang Z, Pan T, Yang B.
Bian Y, et al. Among authors: wang c.
Br J Pharmacol. 2024 Nov 29. doi: 10.1111/bph.17397. Online ahead of print.
Br J Pharmacol. 2024.
PMID: 39614407